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Case report
A 33-year-old male of  Indian and African descent with 
known thalassemia intermedia presented to his hematolo-
gist’s office with acute mid-back pain after lifting boxes 
overhead. His past medical history was significant for 
mixed α and β thalassemia intermedia complicated by iron 
overload, endocrinopathy, osteoporosis, and right ulna and 
radius fractures in 2008. The patient requires at least three 
blood transfusions per year for severe anemia. Mixed α and 
β thalassemia has shown to have better prognosis and 
milder clinical course because of  less α chain imbalance 
(1, 2).
Lumbar radiographs demonstrated severe osteopenia, 
hepatomegaly, splenomegaly, and a wedge-compression 
fracture of  the T12 vertebral body (Fig. 1). MRI demon-
strated diffusely hypointense bone marrow on the T1- and 
T2-weighted images, consistent with red-marrow activation 
secondary to anemia and iron deposition (Fig. 2). An en-
larged, diffusely hypointense liver was seen on the T1-
weighted images, consistent with iron deposition (Fig. 3). A 
DEXA scan from January 2010 reported a lumbar Z score 
of  -4.9, consistent with severe osteoporosis. 
Discussion
Thalassemia is a hemoglobinopathy characterized by 
abnormal globin production of  the α globin chain, β globin 
chain, or both (3). It is one of  the most common genetic 
disorders worldwide, with approximately five percent of  the 
population carrying the globin variant, including 1.7% of  
the population who are heterozygous for the α and β tha-
lassemia trait (3, 4). Men and women are equally affected 
by thalassemia, and it occurs in 4.4 of  every 10,000 births 
(3). Thalassemias can occur in any population. However, α 
thalassemia is more common in Mediterranean countries, 
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Figure 1. 33-year-old male with thalassemia intermedia. AP 
and lateral lumbar radiographs show severe osteopenia, 
hepatosplenomegaly, and T12 compression fracture.
Africa, the Middle East, and southeast Asia. Similarly, β 
thalassemia is commonly seen in Mediterranean, Middle 
Eastern, South Asian, and Southeast Asian countries (3, 4). 
Patients with heterozygotes have a mild microcytic ane-
mia, and those with homozygotes have thalassemia inter-
media or major (depending on the clinical severity). Beta 
thalassemia major patients require blood transfusions from 
an early age, leading to growth failure, bony deformities, 
pathologic fractures, hepatosplenomegaly, and jaundice. 
Clinical manifestations of  β thalassemia intermedia range 
from chronic hemolytic anemia with mild symptoms to 
transfusion-dependent disease with a severity similar to 
thalassemia major (3, 4). Ferritin levels are commonly used 
to monitor iron overload. Improved survival has been 
shown when ferritin levels are less than 2500mg/ml. How-
ever, this value is unreliable when liver disease is present 
(3, 4).
Because of  the variable genetics and complex physiologic 
responses to the disease and therapy, thalassemias have 
clinical variability. The severity of  the disease is directly 
related to the amount of  globin chain imbalance. In β tha-
lassemia, α chains accumulate in the marrow and in red 
blood cells, leading to ineffective marrow erythropoiesis, 
hemolysis, and a hypochromic microcytic anemia. Alpha 
thalassemia also has hemolysis; however, less deficiency in 
erythropoiesis is seen, as the β chains are soluble in the 
marrow. To compensate for the anemia, those affected by β 
thalassemia have increased hemoglobin A2 (α2δ2) and he-
moglobin F (δ2γ2). Alpha thalassemia does not exhibit in-
creased hemoglobins, as the α chain is limiting (3, 4). 
Imaging findings in patients with thalassemias also vary 
depending on the severity of  the disease and globin-chain 
imbalance (1). Visible features include progressive sple-
nomegaly; facial, skull, and bone deformities; osteoporosis; 
and iron deposition within the liver, bone marrow, pan-
creas, myocardium, adrenal glands, and musculoskeletal 
system (3, 4).
Splenomegaly occurs secondary to extramedullary he-
matopoiesis (4). It may be also due to portal venous hyper-
tension secondary to cirrhosis in these patients with iron 
deposition. Facial, skull, and bone deformities are seen sec-
ondary to ineffective erythropoiesis and chronic hemolysis, 
which leads to secondary bone-marrow stimulation and 
results in bone-marrow expansion and deformity (4, 5). 
These facial, skull, and bone deformities can in turn lead to 
pathologic fractures (4, 5).
Osteoporosis has a multifactorial pathogenesis in thalas-
semias, including bone-marrow expansion, endocrine dys-
function, and iron overload. Marrow expansion secondary 
to red-marrow activation from the anemia mechanically 
interrupts bone formation and leads to cortical thinning 
and increased fragility. Hemosiderosis of  the pituitary 
gonadotrophic cells and gonads causes a hypogonado-
trophic state, in which there is high bone turnover with an 
enhanced resorptive phase (4, 5). 
Iron deposition is the most important cause of  morbidity 
and mortality in thalassemia, and it can be quite striking on 
imaging. This iron deposition is seen secondary to the inef-
fective erythropoiesis, which triggers increased gastrointes-
tinal absorption of  iron due to increased marrow demand. 
The iron distribution is similar to that in patients with pri-
mary (genetic) hemachromatosis, where deposition is seen 
within the liver, thyroid, adrenal glands, pituitary gland, 
pancreas, myocardium, and musculoskeletal system. How-
ever, in patients with thalassemia, iron deposition is also 
seen within the bone marrow, unlike patients with primary 
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Figure 2. 33-year-old male with thalassemia intermedia. 
Sagittal T1- and T2-weighted images show T12 compres-
sion fracture and diffusely hypointense marrow.
Figure 3. 33-year-old male with thalassemia intermedia. T1-
weighted coronal image shows markedly enlarged, hypoin-
tense liver and splenomegaly.
hemachromatosis. The spleen may be spared from iron 
deposition in patients with thalassemia even with repetitive 
transfusions, likely secondary to the impared reticuloendo-
thelial cell function. The iron deposition in the liver paren-
chyma over time leads to cirrhosis. An increased rate of  
hepatocellular carcinoma has been demonstrated in these 
patients. Other complications include diabetes mellitus, 
hypoparathyroidism, hypothalamic-pituitary dysfunction 
with hypothyroidism, and hypogonadism (6). The most 
lethal complication is heart failure (1, 4, 6). 
Iron deposition on MR imaging demonstrates decreased 
signal intensity on the T1-weighted, T2-weighted, and T2* 
images. If  liver signal intensity is less than that of  muscle, 
this indicates iron deposition. MR imaging is useful in tha-
lassemia patients to evaluate the extent of  iron deposition 
and to assess for complications of  the disease, such as cir-
rhosis. MR imaging is the least invasive and most sensitive 
and specific imaging technique for the diagnosis and 
evaluation of  iron deposition in thalassemia (6). It can be 
used to follow the effects of  phlebotomy therapy. Quantita-
tion of  hepatic iron deposition is possible but needs liver 
biopsy samples and diligent attention to MRI technique (7). 
Iron deposition is demonstrated by loss of  signal intensity 
within the organs on the T1-weighted images secondary to 
the shortened longitudinal relaxation time; on the T2-
weighted images secondary to the transverse relaxation 
time; and on the T2* images secondary to the transverse 
relaxation time (as affected by magnetic field inhomogene-
ity). The effects of  iron deposition are most apparent on the 
T2* images, and the loss of  signal intensity is proportional 
to the amount of  iron deposition (6).
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